Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

ClinicalTrials.gov ID: NCT00114686

Public ClinicalTrials.gov record NCT00114686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Versus Placebo as Adjunct Therapy With Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients With Bipolar I Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether treatment with Quetiapine Fumarate (SEROQUEL) in conjunction with mood stabilizers (Lithium or Divalproex) for 12 weeks helps patients who have Bipolar I Disorder with Alcohol Dependence

Study identification

NCT ID
NCT00114686
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
350 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2006 (Type not available)
Primary completion
Not listed
Completion
Apr 2007 (Actual)
Last update posted
Jan 4, 2013

2006 – 2007

United States locations

U.S. sites
38
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Research Site Cerritos California — —
Research Site San Diego California — —
Research Site New Haven Connecticut — —
Research Site Jacksonville Florida — —
Research Site Maitland Florida — —
Research Site Orlando Florida — —
Research Site Eagle Idaho — —
Research Site Shreveport Louisiana — —
Research Site Glen Burnie Maryland — —
Research Site Boston Massachusetts — —
Research Site St Louis Missouri — —
Research Site Moorestown New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site New York New York — —
Research Site Staten Island New York — —
Research Site The Bronx New York — —
Research Site Chapel Hill North Carolina — —
Research Site Research Triangle Park North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Cleveland Ohio — —
Research Site Dayton Ohio — —
Research Site Portland Oregon — —
Research Site Media Pennsylvania — —
Research Site Philadelphia Pennsylvania — —
Research Site Pittsburgh Pennsylvania — —
Research Site Columbia South Carolina — —
Research Site Memphis Tennessee — —
Research Site Nashville Tennessee — —
Research Site Austin Texas — —
Research Site Dallas Texas — —
Research Site Houston Texas — —
Research Site San Antonio Texas — —
Research Site Wichita Falls Texas — —
Research Site Richmond Virginia — —
Research Site Bellevue Washington — —
Research Site Kirkland Washington — —
Research Site Seattle Washington — —
Research Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00114686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00114686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →